Summary

Global Vascular Embolization Devices Market 2024-2028
The vascular embolization devices market is forecasted to grow by USD 735.35 mn during 2023-2028, accelerating at a CAGR of 6.69% during the forecast period. The report on the vascular embolization devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of vascular diseases, a rising number of new product launches related to vascular embolization devices, and a growing number of m and activities in related vascular disease products.
Technavio's vascular embolization devices market is segmented as below:
By End-user
• Hospitals
• Speciality clinics
• ASCs
By Product
• Coiling devices
• Non-coiling devices
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the rise in cases of automobile accidents as one of the prime reasons driving the vascular embolization devices market growth during the next few years. Also, funding for start-up embolization device companies from venture capitalists and government organizations and innovation in embolization products and procedures will lead to sizable demand in the market.
The report on the vascular embolization devices market covers the following areas:
• Vascular embolization devices market sizing
• Vascular embolization devices market forecast
• Vascular embolization devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vascular embolization devices market vendors that include Acandis GmbH, B.Braun SE, BALT Group, Boston Scientific Corp., Braile Biomedica, Eisai Co. Ltd., Embolx Inc., Guerbet, Johnson and Johnson Services Inc., Kaneka Corp., Medtronic, Merit Medical Systems Inc., Penumbra Inc., Shape Memory Medical Inc., Spartan Micro Inc., Stryker Corp., Wallby Medical LLC, Terumo Corp., Cook Group Inc., and Abbott Laboratories. Also, the vascular embolization devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/vascular-embolization-devices-market-industry-analysis
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

ページTOPに戻る

Table of Contents

- 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
- 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
- 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- 4 Historic Market Size
o 4.1 Global vascular embolization devices market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global vascular embolization devices market 2018 - 2022 ($ million)
o 4.2 End-user Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
o 4.3 Product Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
- 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
- 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospitals - Market size and forecast 2023-2028
o Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
o 6.4 Speciality clinics - Market size and forecast 2023-2028
o Exhibit 38: Chart on Speciality clinics - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Speciality clinics - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Speciality clinics - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Speciality clinics - Year-over-year growth 2023-2028 (%)
o 6.5 ASCs - Market size and forecast 2023-2028
o Exhibit 42: Chart on ASCs - Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on ASCs - Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on ASCs - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on ASCs - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
- 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Coiling devices - Market size and forecast 2023-2028
o Exhibit 52: Chart on Coiling devices - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Coiling devices - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Coiling devices - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Coiling devices - Year-over-year growth 2023-2028 (%)
o 7.4 Non-coiling devices - Market size and forecast 2023-2028
o Exhibit 56: Chart on Non-coiling devices - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Non-coiling devices - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Non-coiling devices - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Non-coiling devices - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Product
o Exhibit 60: Market opportunity by Product ($ million)
o Exhibit 61: Data Table on Market opportunity by Product ($ million)
- 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 France - Market size and forecast 2023-2028
o Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
- 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
- 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
- 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 111: Abbott Laboratories - Overview
o Exhibit 112: Abbott Laboratories - Business segments
o Exhibit 113: Abbott Laboratories - Key news
o Exhibit 114: Abbott Laboratories - Key offerings
o Exhibit 115: Abbott Laboratories - Segment focus
o 12.4 Acandis GmbH
o Exhibit 116: Acandis GmbH - Overview
o Exhibit 117: Acandis GmbH - Product / Service
o Exhibit 118: Acandis GmbH - Key offerings
o 12.5 BALT Group
o Exhibit 119: BALT Group - Overview
o Exhibit 120: BALT Group - Product / Service
o Exhibit 121: BALT Group - Key offerings
o 12.6 Boston Scientific Corp.
o Exhibit 122: Boston Scientific Corp. - Overview
o Exhibit 123: Boston Scientific Corp. - Business segments
o Exhibit 124: Boston Scientific Corp. - Key news
o Exhibit 125: Boston Scientific Corp. - Key offerings
o Exhibit 126: Boston Scientific Corp. - Segment focus
o 12.7 Braile Biomedica
o Exhibit 127: Braile Biomedica - Overview
o Exhibit 128: Braile Biomedica - Product / Service
o Exhibit 129: Braile Biomedica - Key offerings
o 12.8 Cook Group Inc.
o Exhibit 130: Cook Group Inc. - Overview
o Exhibit 131: Cook Group Inc. - Product / Service
o Exhibit 132: Cook Group Inc. - Key news
o Exhibit 133: Cook Group Inc. - Key offerings
o 12.9 Eisai Co. Ltd.
o Exhibit 134: Eisai Co. Ltd. - Overview
o Exhibit 135: Eisai Co. Ltd. - Business segments
o Exhibit 136: Eisai Co. Ltd. - Key offerings
o Exhibit 137: Eisai Co. Ltd. - Segment focus
o 12.10 Embolx Inc.
o Exhibit 138: Embolx Inc. - Overview
o Exhibit 139: Embolx Inc. - Product / Service
o Exhibit 140: Embolx Inc. - Key offerings
o 12.11 Johnson and Johnson Services Inc.
o Exhibit 141: Johnson and Johnson Services Inc. - Overview
o Exhibit 142: Johnson and Johnson Services Inc. - Business segments
o Exhibit 143: Johnson and Johnson Services Inc. - Key news
o Exhibit 144: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 145: Johnson and Johnson Services Inc. - Segment focus
o 12.12 Medtronic
o Exhibit 146: Medtronic - Overview
o Exhibit 147: Medtronic - Business segments
o Exhibit 148: Medtronic - Key news
o Exhibit 149: Medtronic - Key offerings
o Exhibit 150: Medtronic - Segment focus
o 12.13 Merit Medical Systems Inc.
o Exhibit 151: Merit Medical Systems Inc. - Overview
o Exhibit 152: Merit Medical Systems Inc. - Business segments
o Exhibit 153: Merit Medical Systems Inc. - Key offerings
o Exhibit 154: Merit Medical Systems Inc. - Segment focus
o 12.14 Penumbra Inc.
o Exhibit 155: Penumbra Inc. - Overview
o Exhibit 156: Penumbra Inc. - Product / Service
o Exhibit 157: Penumbra Inc. - Key news
o Exhibit 158: Penumbra Inc. - Key offerings
o 12.15 Shape Memory Medical Inc.
o Exhibit 159: Shape Memory Medical Inc. - Overview
o Exhibit 160: Shape Memory Medical Inc. - Product / Service
o Exhibit 161: Shape Memory Medical Inc. - Key offerings
o 12.16 Stryker Corp.
o Exhibit 162: Stryker Corp. - Overview
o Exhibit 163: Stryker Corp. - Business segments
o Exhibit 164: Stryker Corp. - Key news
o Exhibit 165: Stryker Corp. - Key offerings
o Exhibit 166: Stryker Corp. - Segment focus
o 12.17 Terumo Corp.
o Exhibit 167: Terumo Corp. - Overview
o Exhibit 168: Terumo Corp. - Business segments
o Exhibit 169: Terumo Corp. - Key offerings
o Exhibit 170: Terumo Corp. - Segment focus
- 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations